MetLife Inc

MetLife’s dual $10 B reinsurance and variable annuity deals boost capital, curb risk, and improve underwriting—shaping a stronger future for life‑insurance.

MetLife’s 13% drop in short‑interest signals growing institutional confidence; with solid capital, a low PE, and tech/ESG gains, the insurer offers a value‑growth window for long‑term investors.

MetLife Inc. has demonstrated resilience in a volatile market, with its core business model and diversified customer base positioning it to navigate short-term turbulence and capitalize on emerging growth opportunities.

MetLife Inc.’s stock price has experienced a modest decline of 11.8% over the past year, but remains stable and above its 52-week low, with analysts attributing its premium valuation to its diversified product portfolio and robust capital structure.

MetLife Inc. has demonstrated robust equity performance over the past five years, driven by disciplined capital management, proactive regulatory compliance, and strategic adaptation to evolving market dynamics, positioning it for sustained long-term…

MetLife Inc. has unveiled its ‘New Frontier’ strategy, a comprehensive plan to drive growth and enhance financial performance through four key priorities: solidifying group benefits leadership, expanding its global retirement platform, accelerating …

MetLife Inc.’s stock price has declined, but the company remains committed to its community engagement and outreach efforts, prioritizing grantmaking and community development initiatives.

MetLife Inc. is accelerating its sustainability efforts and positioning itself for growth, but faces challenges from trade policy uncertainty and high valuations.

MetLife’s second-quarter adjusted profit declined 16% due to weaker premiums and less favorable underwriting margins in life and non-medical health products.

MetLife’s stock price is poised for a significant shift as the company prepares to release its Q2 earnings report, a make-or-break moment that will determine its investment prospects.